220 related articles for article (PubMed ID: 36401762)
1. IDH2, a novel target of OGT, facilitates glucose uptake and cellular bioenergy production via NF-κB signaling to promote colorectal cancer progression.
He X; Wu N; Li R; Zhang H; Zhao Y; Nie Y; Wu J
Cell Oncol (Dordr); 2023 Feb; 46(1):145-164. PubMed ID: 36401762
[TBL] [Abstract][Full Text] [Related]
2. OGT-mediated O-GlcNAcylation promotes NF-κB activation and inflammation in acute pancreatitis.
Zhang D; Cai Y; Chen M; Gao L; Shen Y; Huang Z
Inflamm Res; 2015 Dec; 64(12):943-52. PubMed ID: 26407569
[TBL] [Abstract][Full Text] [Related]
3. RIG-I Promotes Cell Viability, Colony Formation, and Glucose Metabolism and Inhibits Cell Apoptosis in Colorectal Cancer by NF-
Liu Y; Ye S; Zhu Y; Chen L; Zhang Z
Dis Markers; 2022; 2022():1247007. PubMed ID: 35242239
[TBL] [Abstract][Full Text] [Related]
4. Single cell and bulk RNA expression analyses identify enhanced hexosamine biosynthetic pathway and O-GlcNAcylation in acute myeloid leukemia blasts and stem cells.
Schauner R; Cress J; Hong C; Wald D; Ramakrishnan P
Front Immunol; 2024; 15():1327405. PubMed ID: 38601153
[TBL] [Abstract][Full Text] [Related]
5.
Zhang H; Qi J; Pei J; Zhang M; Shang Y; Li Z; Wang Y; Guo J; Sun K; Fan J; Sui L; Xu Y; Kong L; Kong Y
J Adv Res; 2022 Mar; 37():119-131. PubMed ID: 35499042
[TBL] [Abstract][Full Text] [Related]
6. A novel NF-κB regulator encoded by circPLCE1 inhibits colorectal carcinoma progression by promoting RPS3 ubiquitin-dependent degradation.
Liang ZX; Liu HS; Xiong L; Yang X; Wang FW; Zeng ZW; He XW; Wu XR; Lan P
Mol Cancer; 2021 Aug; 20(1):103. PubMed ID: 34412652
[TBL] [Abstract][Full Text] [Related]
7. Ogt-mediated O-GlcNAcylation inhibits astrocytes activation through modulating NF-κB signaling pathway.
Dong X; Shu L; Zhang J; Yang X; Cheng X; Zhao X; Qu W; Zhu Q; Shou Y; Peng G; Sun B; Yi W; Shu Q; Li X
J Neuroinflammation; 2023 Jun; 20(1):146. PubMed ID: 37349834
[TBL] [Abstract][Full Text] [Related]
8. O-GlcNAcylation of ITGA5 facilitates the occurrence and development of colorectal cancer.
Yu M; Chu S; Fei B; Fang X; Liu Z
Exp Cell Res; 2019 Sep; 382(2):111464. PubMed ID: 31202709
[TBL] [Abstract][Full Text] [Related]
9. Downregulation of
Jiao HL; Ye YP; Yang RW; Sun HY; Wang SY; Wang YX; Xiao ZY; He LQ; Cai JJ; Wei WT; Chen YR; Gu CC; Cai YL; Hu YT; Lai QH; Qiu JF; Liang L; Cao GW; Liao WT; Ding YQ
Clin Cancer Res; 2017 Nov; 23(22):7108-7118. PubMed ID: 28912140
[No Abstract] [Full Text] [Related]
10. O-GlcNAc transferase promotes fatty liver-associated liver cancer through inducing palmitic acid and activating endoplasmic reticulum stress.
Xu W; Zhang X; Wu JL; Fu L; Liu K; Liu D; Chen GG; Lai PB; Wong N; Yu J
J Hepatol; 2017 Aug; 67(2):310-320. PubMed ID: 28347804
[TBL] [Abstract][Full Text] [Related]
11. Colorectal cancer cell-derived CCL20 recruits regulatory T cells to promote chemoresistance via FOXO1/CEBPB/NF-κB signaling.
Wang D; Yang L; Yu W; Wu Q; Lian J; Li F; Liu S; Li A; He Z; Liu J; Sun Z; Yuan W; Zhang Y
J Immunother Cancer; 2019 Aug; 7(1):215. PubMed ID: 31395078
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of Fatty Acid Synthase Upregulates Glutamine-Fructose-6-Phosphate Transaminase 1 and O-Linked N-Acetylglucosamine Transferase to Increase O-GlcNAc Protein Glycosylation and Promote Colorectal Cancer Growth.
Drury J; Geisen ME; Tessmann JW; Rychahou PG; Kelson CO; He D; Wang C; Evers BM; Zaytseva YY
Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38732103
[TBL] [Abstract][Full Text] [Related]
13. Augmented TME
Moriwaki K; Asahi M
Mol Cancer Res; 2017 Sep; 15(9):1287-1298. PubMed ID: 28536142
[No Abstract] [Full Text] [Related]
14. Mechanistic insights of O-GlcNAcylation that promote progression of cholangiocarcinoma cells via nuclear translocation of NF-κB.
Phoomak C; Vaeteewoottacharn K; Sawanyawisuth K; Seubwai W; Wongkham C; Silsirivanit A; Wongkham S
Sci Rep; 2016 Jun; 6():27853. PubMed ID: 27290989
[TBL] [Abstract][Full Text] [Related]
15. m
Shen C; Xuan B; Yan T; Ma Y; Xu P; Tian X; Zhang X; Cao Y; Ma D; Zhu X; Zhang Y; Fang JY; Chen H; Hong J
Mol Cancer; 2020 Apr; 19(1):72. PubMed ID: 32245489
[TBL] [Abstract][Full Text] [Related]
16. O-GlcNAcylation of CSNK2A1 by OGT is Involved in the Progression of Colorectal Cancer.
Yu Z; He H; Jiang B; Hu J
Mol Biotechnol; 2024 Jan; ():. PubMed ID: 38289573
[TBL] [Abstract][Full Text] [Related]
17. IL-33 facilitates proliferation of colorectal cancer dependent on COX2/PGE
Li Y; Shi J; Qi S; Zhang J; Peng D; Chen Z; Wang G; Wang Z; Wang L
J Exp Clin Cancer Res; 2018 Aug; 37(1):196. PubMed ID: 30119635
[TBL] [Abstract][Full Text] [Related]
18. Downregulation of IDH2 exacerbates the malignant progression of osteosarcoma cells via increased NF-κB and MMP-9 activation.
Yi WR; Li ZH; Qi BW; Ernest ME; Hu X; Yu AX
Oncol Rep; 2016 Apr; 35(4):2277-85. PubMed ID: 26782630
[TBL] [Abstract][Full Text] [Related]
19. FMNL2 destabilises COMMD10 to activate NF-κB pathway in invasion and metastasis of colorectal cancer.
Yang SS; Li XM; Yang M; Ren XL; Hu JL; Zhu XH; Wang FF; Zeng ZC; Li JY; Cheng ZQ; Liao WT; Ding YQ; Guan J; Liang L
Br J Cancer; 2017 Oct; 117(8):1164-1175. PubMed ID: 28817833
[TBL] [Abstract][Full Text] [Related]
20. Hyper-O-GlcNAcylation is anti-apoptotic and maintains constitutive NF-κB activity in pancreatic cancer cells.
Ma Z; Vocadlo DJ; Vosseller K
J Biol Chem; 2013 May; 288(21):15121-30. PubMed ID: 23592772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
